€25 million investment helps HTBA produce all active forms of B12

€25 million investment helps HTBA produce all active forms of B12

HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain. The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin…


HealthTech BioActives (HTBA) has completed a €25 million investment project to modernise its research, development and manufacturing centre in Murcia, Spain.

The initiative included the construction of a new state-of-the-art production plant, which was officially inaugurated on Tuesday 28 January, making HTBA the only company in Europe capable of producing all active forms of vitamin B12, reinforcing its status as a leader in the industry.

The multi-million-euro project aimed to introduce advanced manufacturing processes and sustainability measures to strengthen HTBA’s position as a prominent player in the sector and reduce its environmental footprint.

The investment also involved the modernisation of the company’s existing citrus flavonoid production plant, enabling further development of HTBA’s patented manufacturing process for a specific type of flavonoid, diosmin – an ingredient that can help promote blood circulation and address vascular discomfort. This new production process replaces artificial solvents with water. As a result, HTBA is now the only company in the world capable of manufacturing diosmin without the use of artificial solvents.

“Our origins in citrus flavonoids and vitamin B12 date back more than 45 years and this innovation project marks a huge milestone for HTBA, demonstrating our unwavering dedication to producing high-quality, environmentally responsible products on a global scale,” comments Alexandre Valls-Coma, chief executive officer of HTBA. “Through this significant investment, we’re not only reinforcing our global leadership in the production of active forms of vitamin B12 and citrus flavonoids, but we’re also furthering our commitment to upholding the highest standards in sustainability and innovation.”

In line with the company’s ongoing commitment to sustainability, the new and upgraded facilities harness advanced technology and automation systems that support the use of renewable energy and optimise resource consumption. Overall, the investment has enabled 98% of waste generated to be recovered, revalued or recycled.

Related content


Stories for you


  • H55 moves B23 Energic towards market

    H55 moves B23 Energic towards market

    Battery certification is becoming aircraft integration at commercial pace now. H55 delivered conforming modules to BRM Aero, with first customer deliveries planned for late 2027 as the electric trainer moves toward market.


  • Hoyer VMS posts records after merger

    Hoyer VMS posts records after merger

    A post-merger motor group is already reporting record numbers globally. Hoyer VMS says demand across industrial motors, automation, and marine services pushed 2025 revenue to DKK 867 million, with expected group revenue of DKK 1.5 billion in 2026.